Mark E. Layton

983 citations
26 papers · 817 · h-index 14

Impact in

    • Synthetic Organic Chemistry Methods
    • Asymmetric Synthesis and Catalysis
    • Catalytic C–H Functionalization Methods
    • Oxidative Organic Chemistry Reactions

Papers in

    • Microbial Natural Products and Biosynthesis 4
    • Cholinesterase and Neurodegenerative Diseases 4
    • Chemical synthesis and alkaloids 4
    • Synthetic Organic Chemistry Methods 2

Mark E. Layton

25 papers receiving 747 citations

Peers

Mark E. Layton
Comparison fields: 5 of 75
  • Organic Chemistry 479
  • Biotechnology 65
  • Cellular and Molecular Neuroscience 130
  • Pharmacology 112
  • Process Chemistry and Technology 19
Replace Andrew P. Degnan with:
Andrew P. Degnan United States
Peter C. Astles United Kingdom
Mark A. Sanner United States
Daniel J. Buzard United States
Andrew J. Culshaw United Kingdom
Lawrence R. Marcin United States
Thilo Focken Canada
Jae‐Kyu Jung United States
Derek J. Denhart United States
Georg Kettschau Germany
Mark E. Layton relative to Andrew P. Degnan United States Andrew P. Degnan's profile →
Citations per field
00.5×2×3.2×
Andrew P. Degnan · 1×
Citations per year

Countries citing papers authored by Mark E. Layton

Since Specialization
Citations

This map shows the geographic impact of Mark E. Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Layton more than expected).

Fields of papers citing papers by Mark E. Layton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Layton. The network helps show where Mark E. Layton may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Layton Line = papers co-authored together Mark E. Layton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2002191
2 200083
3 200879
4 200073
5 200659
6 201039
7 199838
8 200438
9 201736
10 201732
11 202328
12 201123
13 202120
14 202417
15 200514
16 20219
17 20168
18 20167
19 20167
20 20184

About Mark E. Layton

Mark E. Layton is a scholar working on Pharmacology, Organic Chemistry, Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 817 indexed citations. Recurring topics across this work include Ion channel regulation and function (8 papers), Neuroscience and Neuropharmacology Research (5 papers), Chemical synthesis and alkaloids (4 papers), Microbial Natural Products and Biosynthesis (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Phosphodiesterase function and regulation (3 papers) and Synthetic Organic Chemistry Methods (2 papers). The work is most often cited by research in Organic Chemistry (479 citations), Biotechnology (65 citations), Cellular and Molecular Neuroscience (130 citations), Pharmacology (112 citations) and Process Chemistry and Technology (19 citations). Mark E. Layton has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Matthew D. Shair, Chuo Chen, Michael J. Kelly, Craig W. Lindsley, Mark T. Bilodeau, Stanley F. Barnett, Scott M. Sheehan, Jason M. Uslaner, Sarah L. Huszar and Kerry L. Fillgrove. Their work appears in journals such as Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Current Topics in Medicinal Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact